The team, from biopharmaceutical company Regeneron, hopes their work will help researchers better understand protein-protein interactions during preclinical development of a drug. “Essentially, we ...

This article explores the development, full optimization and validation study of a highly sensitive and selective ELISA for determination of cetuximab (CET) in human plasma samples. CET was captured ...

Biotechnology has turned cells into machines capable of making biological medicines that are more effective and better targeted than traditional drugs. But manufacturing biopharmaceuticals in a living ...